Invest along side VC’s and PE for access to high return startup flow. 
- Cure Ventures launches to support life sciences companies Labiotech.eu
- Cure Ventures Launches with $350M to De-Risk Innovation BioSpace
- Biotech gets a new VC firm, built by industry veterans STAT
- Five things you need to know today, plus socks with sandals – Boston Business Journal Boston Business Journal
- Cure Ventures unveils inaugural $350M fund FierceBiotech
- View Full coverage on Google News
